Vico Therapeutics
Series B in 2024
Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.
Vico Therapeutics
Series B in 2024
Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.
Camlin Fine Sciences
Post in 2023
Camlin Fine Sciences Limited, headquartered in Mumbai, India, specializes in the research, development, manufacture, and marketing of specialty chemicals and additive blends across various global markets, including India, North and Central America, Europe, and Asia. The company offers a diverse range of products, including shelf-life solutions like antioxidants and natural extracts that enhance the longevity of food and feed, marketed under the Xtendra and NaSure brands. Additionally, Camlin provides aroma ingredients such as vanillin and ethyl vanillin, and a variety of nutraceutical products derived from fermentation and green extraction. Its performance chemicals include hydroquinone and catechol, while its fine chemicals encompass a wide array of compounds. Furthermore, the company manufactures animal nutrition products, which include growth promoters and antimicrobials, with applications spanning the food and beverage, pharmaceutical, and petrochemical industries, among others. Established in 1931, Camlin Fine Sciences was previously known as Camlin Fine Chemicals Limited before rebranding in 2011.
AstriVax
Seed Round in 2022
AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
Medikabazaar
Series D in 2022
Medikabazaar is an online B2B marketplace specializing in medical supplies and equipment, serving both medical institutions and individual practitioners. The platform simplifies procurement by allowing users to search, compare, and purchase medical products through a voice-based search engine and an online payment portal, thus reducing operational costs. With a network of over 50,000 medical establishments and 150,000 independent practitioners across India, Medikabazaar partners with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. The company's strategic use of technology has helped organize the complex medical supply market in India, ensuring the availability of global brands at a local level. Additionally, Medikabazaar boasts a robust last-mile delivery system supported by 26 fulfillment centers nationwide, which facilitates the timely delivery of essential medical supplies and enhances the quality of patient care.
Medikabazaar
Series C in 2021
Medikabazaar is an online B2B marketplace specializing in medical supplies and equipment, serving both medical institutions and individual practitioners. The platform simplifies procurement by allowing users to search, compare, and purchase medical products through a voice-based search engine and an online payment portal, thus reducing operational costs. With a network of over 50,000 medical establishments and 150,000 independent practitioners across India, Medikabazaar partners with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. The company's strategic use of technology has helped organize the complex medical supply market in India, ensuring the availability of global brands at a local level. Additionally, Medikabazaar boasts a robust last-mile delivery system supported by 26 fulfillment centers nationwide, which facilitates the timely delivery of essential medical supplies and enhances the quality of patient care.
Medikabazaar
Series B in 2020
Medikabazaar is an online B2B marketplace specializing in medical supplies and equipment, serving both medical institutions and individual practitioners. The platform simplifies procurement by allowing users to search, compare, and purchase medical products through a voice-based search engine and an online payment portal, thus reducing operational costs. With a network of over 50,000 medical establishments and 150,000 independent practitioners across India, Medikabazaar partners with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. The company's strategic use of technology has helped organize the complex medical supply market in India, ensuring the availability of global brands at a local level. Additionally, Medikabazaar boasts a robust last-mile delivery system supported by 26 fulfillment centers nationwide, which facilitates the timely delivery of essential medical supplies and enhances the quality of patient care.
MRM Health NV
Series A in 2020
MRM Health NV is a biopharmaceutical company based in Ghent, Belgium, that specializes in developing microbiome-based therapeutics for metabolic diseases. Founded in early 2020 as a subsidiary of MRM Technologies, the company collaborates with the Flemish Institute of Biotechnology (VIB) to translate scientific research into practical applications. MRM Health is focused on innovative drug development, particularly its lead candidate MH002, aimed at treating Inflammatory Bowel Disease (IBD), which encompasses conditions such as Ulcerative Colitis and Crohn's disease. Through its research and development efforts, MRM Health seeks to advance therapeutic options based on the human microbiome.
OncoDNA is a theranostic and genomic company that specializes in precision medicine for cancer and genetic diseases. Founded by a team with over 60 years of experience in medical diagnostics, the company focuses on providing clinical guidance for the treatment and real-time monitoring of late-stage cancer patients. OncoDNA supports researchers and biopharma companies in navigating the complexities of molecular biology, facilitating research and drug development in oncology. With its commitment to delivering precision medicine, OncoDNA aims to enhance treatment outcomes and improve the management of cancer and genetic disorders.
Medikabazaar
Series B in 2019
Medikabazaar is an online B2B marketplace specializing in medical supplies and equipment, serving both medical institutions and individual practitioners. The platform simplifies procurement by allowing users to search, compare, and purchase medical products through a voice-based search engine and an online payment portal, thus reducing operational costs. With a network of over 50,000 medical establishments and 150,000 independent practitioners across India, Medikabazaar partners with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. The company's strategic use of technology has helped organize the complex medical supply market in India, ensuring the availability of global brands at a local level. Additionally, Medikabazaar boasts a robust last-mile delivery system supported by 26 fulfillment centers nationwide, which facilitates the timely delivery of essential medical supplies and enhances the quality of patient care.
Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.
Biolectric
Acquisition in 2019
Biolectric specializes in the development of biogas installation systems designed to enhance the biogas energy production sector. The company employs a process that microbiologically converts organic material into biogas under anaerobic conditions, without introducing additional organic biological waste. This innovative approach allows clients to lower energy production costs while promoting environmentally friendly energy solutions. By effectively matching supply with demand, Biolectric provides a sustainable and durable energy alternative.
OncoDNA is a theranostic and genomic company that specializes in precision medicine for cancer and genetic diseases. Founded by a team with over 60 years of experience in medical diagnostics, the company focuses on providing clinical guidance for the treatment and real-time monitoring of late-stage cancer patients. OncoDNA supports researchers and biopharma companies in navigating the complexities of molecular biology, facilitating research and drug development in oncology. With its commitment to delivering precision medicine, OncoDNA aims to enhance treatment outcomes and improve the management of cancer and genetic disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.